These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 7861986)

  • 1. Effects of continuous exposure to ciprofloxacin on the outer membrane of P. aeruginosa.
    Magni A; Giordano A; Papa F; de Vito D; Cipriani P
    New Microbiol; 1994 Oct; 17(4):307-12. PubMed ID: 7861986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outer membrane alterations in Pseudomonas aeruginosa after five-day exposure to quinolones and carbapenems.
    Cipriani P; Giordano A; Magni A; Papa F; Filadoro F
    Drugs Exp Clin Res; 1995; 21(4):139-44. PubMed ID: 8529526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outer membrane proteins and lipopolysaccharide changes after exposure of Pseudomonas aeruginosa to antibacterial drugs.
    Giordano A; Magni A; Trancassini M; Cipriani P
    New Microbiol; 1993 Jul; 16(3):281-6. PubMed ID: 8366824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of amikacin-resistant Pseudomonas aeruginosa developing in patients receiving amikacin.
    Maloney J; Rimland D; Stephens DS; Terry P; Whitney AM
    Arch Intern Med; 1989 Mar; 149(3):630-4. PubMed ID: 2493230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model.
    Zinner SH; Vostrov SN; Alferova IV; Lubenko IY; Portnoy YA; Firsov AA
    Int J Antimicrob Agents; 2004 Aug; 24(2):173-7. PubMed ID: 15288317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa.
    Pasquali F; Manfreda G
    Vet Microbiol; 2007 Jan; 119(2-4):304-10. PubMed ID: 16987619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ciprofloxacin in its synergistic effect with fosfomycin on drug-resistant strains of Pseudomonas aeruginosa.
    Yamada S; Hyo Y; Ohmori S; Ohuchi M
    Chemotherapy; 2007; 53(3):202-9. PubMed ID: 17356268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rhamnolipid-biosurfactant on cell surface of Pseudomonas aeruginosa.
    Sotirova A; Spasova D; Vasileva-Tonkova E; Galabova D
    Microbiol Res; 2009; 164(3):297-303. PubMed ID: 17416508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of temperature on the bactericidal activities of ciprofloxacin and levofloxacin against Escherichia coli and Pseudomonas aeruginosa.
    Parte AC; Smith JT
    Microbios; 1994; 80(322):31-9. PubMed ID: 7854197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Composition of the outer membrane proteins of Escherichia coli strains in relation to serum susceptibility after exposure to subinhibitory concentrations of amikacin and ciprofloxacin.
    Wojnicz D; Cisowska A
    Int J Antimicrob Agents; 2009 Jun; 33(6):579-82. PubMed ID: 19232480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
    Lei YC; Wang HB; Sun ZY; Shen ZY
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Release of DNA from Pseudomonas aeruginosa in vitro during spontaneous growth and treatment with ciprofloxacin].
    Peng DZ; Guymon CH; McManus AT; Xiao GX
    Zhonghua Wai Ke Za Zhi; 2005 Feb; 43(3):178-81. PubMed ID: 15842899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiles of outer membrane proteins and lipopolysaccharide of Pseudomonas aeruginosa grown in the presence of sub-MICs of macrolide antibiotics and their relation to enhanced serum sensitivity.
    Tateda K; Ishii Y; Hirakata Y; Matsumoto T; Ohno A; Yamaguchi K
    J Antimicrob Chemother; 1994 Dec; 34(6):931-42. PubMed ID: 7730236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to ciprofloxacin appearing during therapy.
    Chin NX; Clynes N; Neu HC
    Am J Med; 1989 Nov; 87(5A):28S-31S. PubMed ID: 2511760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of outer membrane permeabilisation on intrinsic resistance to low triclosan levels in Pseudomonas aeruginosa.
    Champlin FR; Ellison ML; Bullard JW; Conrad RS
    Int J Antimicrob Agents; 2005 Aug; 26(2):159-164. PubMed ID: 16040235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriostatic and bactericidal activities of eight fluoroquinolones against MexAB-OprM-overproducing clinical strains of Pseudomonas aeruginosa.
    Dupont P; Hocquet D; Jeannot K; Chavanet P; Plésiat P
    J Antimicrob Chemother; 2005 Apr; 55(4):518-22. PubMed ID: 15722391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas aeruginosa deficient in 8-oxodeoxyguanine repair system shows a high frequency of resistance to ciprofloxacin.
    Morero NR; Argaraña CE
    FEMS Microbiol Lett; 2009 Jan; 290(2):217-26. PubMed ID: 19025574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant prevention concentration for ciprofloxacin and levofloxacin with Pseudomonas aeruginosa.
    Hansen GT; Zhao X; Drlica K; Blondeau JM
    Int J Antimicrob Agents; 2006 Feb; 27(2):120-4. PubMed ID: 16426820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of cross-resistance following exposure of Pseudomonas aeruginosa clinical isolates to ciprofloxacin or cefepime.
    Alyaseen SA; Piper KE; Rouse MS; Steckelberg JM; Patel R
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2543-5. PubMed ID: 15917569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.